Labcorp Q2 Earnings Preview: Diagnostics Strength in Focus

Key Takeaways LH's Q2 revenues are estimated to be $3.49B, up 8.3% year over year, with EPS expected to rise 5.1% to $4.14. Diagnostics growth is driven by acquisitions, partnerships, and expanded specialty lab services. New Alzheimer's and oncology tests likely supported LH's top-line gains in the second quarter.Labcorp Holdings Inc. (LH) , or Labcorp, is slated to report second-quarter 2025 results on July 24, before the opening bell.The renowned laboratory service provider reported adjusted earnings of ...